Table 4.
miRNA | Deregulation | Cells | Functional assaya | Target genes | Reference |
---|---|---|---|---|---|
124 | Down | Primary human MB, cell lines | ↑Cell cycle progression at G1 | CDK6 | (48, 49) |
↓Cell proliferation | SLC16A1 | ||||
324-5p | Down | Primary human and mouse MB, cell lines | ↓Cell proliferation | SMO | (50) |
326 | GLI1 | ||||
125p | |||||
9 | Down | Primary human MB, cell lines | ↑Apoptosis | Trkc | (12) |
125a | ↓Cell proliferation | ||||
199b-5p | Up | Primary human and mouse MB, cell lines | ↑Cell cycle progression at G1 | HES1 | (28) |
↓Cell proliferation | |||||
128 | Down | Primary human and mouse MB | ↓Cell proliferation | BMI-1 | (51) |
↑Cell senescence | |||||
21 | Up | Primary human MB, cell lines | ↓Cell migration | PDCD4 | (31) |
935 | Down | Primary human MB, cell lines | – | KIAA0232 | (52 ) |
SLC5A3 | |||||
TBC1D9 | |||||
ZFAND6 | |||||
34a | Down | MB cell lines | ↑Apoptosis | MAGE-A | (30, 53) |
↑Cell cycle progression at S/phase and G2/M | Dll1 | ||||
↓Cell proliferation | Notch1 | ||||
↑Cell senescence | Notch2 | ||||
512-5p | Down | Primary human MB, cell lines | – | MYCC | (54 ) |
383 | Down | Primary human MB, cell lines | ↑Apoptosis | PRDX3 | (55, 56) |
↑Cell cycle progression at G1 | |||||
↓Cell proliferation | |||||
183 ∼96 ∼ | Down | MB cell lines | ↑Cell cycle progression at | AKT | (57) |
182 | G0/G1 and G2 | ||||
↓Cell migration | |||||
↓Cell proliferation | |||||
218 | Down | MB cell lines | ↓Cell migration | CDK6 | (58) |
↓Cell proliferation | REST |
Underlined miRNAs are miRNAs also found deregulated in the present study;
aresults of ectopic expression or knockdown assays; MB = medulloblastoma.